| Style | Citing Format |
|---|---|
| MLA | Mancini I, et al.. "Assessing Genetic Risk Factors for Early-Onset Coronary Artery Disease in Iranians." Research and Practice in Thrombosis and Haemostasis, vol. 10, no. 6, 2026, pp. -. |
| APA | Mancini I, Pagliari M T, Sadeghian S, Abbasi S H, Poorhosseini H, Boroumand M A, Lotfi Tokaldany M, Pappalardo E, Agosti P, Rosendaal F R, Peyvandi F (2026). Assessing Genetic Risk Factors for Early-Onset Coronary Artery Disease in Iranians. Research and Practice in Thrombosis and Haemostasis, 10(6), -. |
| Chicago | Mancini I, Pagliari M T, Sadeghian S, Abbasi S H, Poorhosseini H, Boroumand M A, Lotfi Tokaldany M, et al.. "Assessing Genetic Risk Factors for Early-Onset Coronary Artery Disease in Iranians." Research and Practice in Thrombosis and Haemostasis 10, no. 6 (2026): -. |
| Harvard | Mancini I et al. (2026) 'Assessing Genetic Risk Factors for Early-Onset Coronary Artery Disease in Iranians', Research and Practice in Thrombosis and Haemostasis, 10(6), pp. -. |
| Vancouver | Mancini I, Pagliari M T, Sadeghian S, Abbasi S H, Poorhosseini H, Boroumand M A, et al.. Assessing Genetic Risk Factors for Early-Onset Coronary Artery Disease in Iranians. Research and Practice in Thrombosis and Haemostasis. 2026;10(6):-. |
| BibTex | @article{ author = {Mancini I and Pagliari M T and Sadeghian S and Abbasi S H and Poorhosseini H and Boroumand M A and Lotfi Tokaldany M and Pappalardo E and Agosti P and Rosendaal F R and Peyvandi F}, title = {Assessing Genetic Risk Factors for Early-Onset Coronary Artery Disease in Iranians}, journal = {Research and Practice in Thrombosis and Haemostasis}, volume = {10}, number = {6}, pages = {-}, year = {2026} } |
| RIS | TY - JOUR AU - Mancini I AU - Pagliari M T AU - Sadeghian S AU - Abbasi S H AU - Poorhosseini H AU - Boroumand M A AU - Lotfi Tokaldany M AU - Pappalardo E AU - Agosti P AU - Rosendaal F R AU - Peyvandi F TI - Assessing Genetic Risk Factors for Early-Onset Coronary Artery Disease in Iranians JO - Research and Practice in Thrombosis and Haemostasis VL - 10 IS - 6 SP - EP - PY - 2026 ER - |